SODI Solitron Devices Inc (PK)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SEC FILE NUMBER

001-04978

CUSIP NUMBER

834256208

(Check one):

☒

Form 10-K

Form 20-F

Form 11-K

Form 10-Q

Form 10-D

☐

Form N-CEN

Form N-CSR

FEBRUARY 28, 2023

☐

Transition Report on Form 10-K

☐

Transition Report on Form 20-F

☐

Transition Report on Form 11-K

☐

Transition Report on Form 10-Q

For the Transition Period Ended: ______________________________________

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I -- REGISTRANT INFORMATION

Solitron Devices, Inc.

Full Name of Registrant

Former Name if Applicable

901 Sansburys Way

Address of Principal Executive Office (Street and Number)

West Palm Beach, Florida 33411

City, State and Zip Code

(a)

The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

☒

(b)

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

(c)

The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

(1)

Name and telephone number of person to contact in regard to this notification

TIM ERIKSEN

(561)

848-4311

(Name)

(Area Code)

(Telephone Number)

(2)

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If answer is no, identify report(s).

(3)

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

Unaudited net sales for fiscal 2023, fiscal year ending February 28, 2023, were approximately $6.4 million versus $12.3 million in fiscal 2022, fiscal year ending February 28, 2022.  Lower sales were due to accelerating shipments in fiscal 2022 prior to moving into the company’s new facility during fiscal 2023. We had minimal sales in the fiscal 2023 third quarter due to the move into the new facility, which required stoppage of production, recertification and start up.  Unaudited cost of sales were $5.0 million in fiscal 2023 versus $7.5 million for fiscal 2022.  Unaudited selling, general and administrative expenses were approximately $2.1 million for fiscal 2023 versus $2.5 million for fiscal 2022.  Unaudited other income for fiscal 2023 was approximately $1.5 million versus $1.2 million for fiscal 2022.  Preliminary unaudited net income for fiscal 2023 was approximately $0.8 million versus $3.5 million for fiscal 2022.

Date

June 1, 2023

By

/s/ Tim Eriksen

CHIEF EXECUTIVE OFFICER

AND CHIEF FINANCIAL OFFICER